APA (7th ed.) Citation

M, T., L, S., S, M., M, S., A, B., F, M., . . . F, C. (2025). Antitumor Efficacy and Immunomodulation of H‑Ferritin Nanocaged Doxorubicin for Triple Negative Breast Cancer. ACS applied nano materials, 8(45), 21724. https://doi.org/10.1021/acsanm.5c03120

Chicago Style (17th ed.) Citation

M, Truffi, et al. "Antitumor Efficacy and Immunomodulation of H‑Ferritin Nanocaged Doxorubicin for Triple Negative Breast Cancer." ACS Applied Nano Materials 8, no. 45 (2025): 21724. https://doi.org/10.1021/acsanm.5c03120.

MLA (9th ed.) Citation

M, Truffi, et al. "Antitumor Efficacy and Immunomodulation of H‑Ferritin Nanocaged Doxorubicin for Triple Negative Breast Cancer." ACS Applied Nano Materials, vol. 8, no. 45, 2025, p. 21724, https://doi.org/10.1021/acsanm.5c03120.